Combined use of the CLivD score and FIB-4 for prediction of liver-related outcomes in the population.
Fredrik O ÅbergJuho AsteljokiVille MännistöPanu K LuukkonenPublished in: Hepatology (Baltimore, Md.) (2023)
The CLivD score is a valid tool for LRO risk assessment and improves the predictive performance of FIB-4. The combined use of CLivD and FIB-4 identified a subgroup where 1 in 3 individuals developed LROs within 10 years.